Nihon M&A Center Holdings Inc. Logo

Nihon M&A Center Holdings Inc.

M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.

2127 | T

Overview

Corporate Details

ISIN(s):
JP3689050007
LEI:
Country:
Japan
Address:
千代田区丸の内一丁目8番2号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Nihon M&A Center Holdings Inc., established in 1991, is a leading mergers and acquisitions (M&A) advisory firm in Japan. The company specializes in providing comprehensive M&A brokerage and consulting services, with a primary focus on small and medium-sized enterprises (SMEs). It supports clients through the entire deal lifecycle, offering services such as M&A intermediation, corporate assessment and valuation, management buyout (MBO) support, and restructuring aid. In addition to its significant domestic presence, the firm facilitates cross-border M&A transactions, helping to integrate Japanese SMEs with the global economy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 05:21
Report Publication Announcement
確認書
Japanese 8.8 KB
2025-11-12 05:20
Interim Report
半期報告書-第35期(2025/04/01-2026/03/31)
Japanese 229.1 KB
2025-06-27 05:03
Post-Annual General Meeting Information
臨時報告書
Japanese 27.9 KB
2025-06-24 07:45
Governance Information
内部統制報告書-第34期(2024/04/01-2025/03/31)
Japanese 24.9 KB
2025-06-24 07:45
Registration Form
確認書
Japanese 8.9 KB
2025-06-24 07:44
Registration Form
有価証券報告書-第34期(2024/04/01-2025/03/31)
Japanese 2.0 MB
2024-11-14 08:09
Interim Report
確認書
Japanese 8.8 KB
2024-11-14 08:08
Interim Report
半期報告書-第34期(2024/04/01-2025/03/31)
Japanese 227.9 KB
2024-06-26 06:41
Post-Annual General Meeting Information
臨時報告書
Japanese 30.1 KB
2024-06-25 07:58
Annual Report
有価証券報告書-第33期(2023/04/01-2024/03/31)
Japanese 1.5 MB
2024-06-25 07:58
Governance Information
内部統制報告書-第33期(2023/04/01-2024/03/31)
Japanese 23.5 KB
2024-06-25 07:58
Registration Form
確認書
Japanese 8.8 KB
2024-06-17 09:10
Major Shareholding Notification
臨時報告書
Japanese 22.9 KB
2024-02-14 06:58
Quarterly Report
四半期報告書-第33期第3四半期(2023/10/01-2023/12/31)
Japanese 182.7 KB
2024-02-14 06:58
Report Publication Announcement
確認書
Japanese 8.8 KB

Automate Your Workflow. Get a real-time feed of all Nihon M&A Center Holdings Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nihon M&A Center Holdings Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nihon M&A Center Holdings Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.